Vulvar Squamous Cell Carcinoma
Also known as: Vulva Squamous Cell Carcinoma / Squamous Cell Carcinoma (SCC) of the Vulva / Squamous Cell Vulvar Carcinoma / Squamous cell carcinoma of the vulva / Squamous cell carcinoma of vulva (disorder)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11714 | Durvalumab | 1 | Completed | 1 |
| DB09037 | Pembrolizumab | 1 | Completed | 1 |
| DB11771 | Tremelimumab | 1 | Completed | 1 |
| DB00544 | Fluorouracil | 1 / 2 | Recruiting | 1 |
| DB00650 | Leucovorin | 1 / 2 | Recruiting | 1 |
| DB11793 | Niraparib | 1 / 2 | Recruiting | 1 |
| DB16186 | PEN-866 | 1 / 2 | Recruiting | 1 |
| DB00958 | Carboplatin | 2 | Recruiting | 1 |
| DB00515 | Cisplatin | 2 | Active Not Recruiting | 1 |
| DB00515 | Cisplatin | 2 | Completed | 1 |
| DB00515 | Cisplatin | 2 | Recruiting | 1 |
| DB00441 | Gemcitabine | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB13896 | Talimogene laherparepvec | 2 | Active Not Recruiting | 1 |